Cargando…
Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast
There are many studies that show biological differences between invasive ductal carcinoma (IDC) with and without nodal metastasis, but no prognostic classification taking into consideration any biological differences between them is currently available. We previously investigated the histological ch...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361891/ https://www.ncbi.nlm.nih.gov/pubmed/15756255 http://dx.doi.org/10.1038/sj.bjc.6602353 |
_version_ | 1782153325978845184 |
---|---|
author | Hasebe, T Sasaki, S Imoto, S Wada, N Ishii, G Ochiai, A |
author_facet | Hasebe, T Sasaki, S Imoto, S Wada, N Ishii, G Ochiai, A |
author_sort | Hasebe, T |
collection | PubMed |
description | There are many studies that show biological differences between invasive ductal carcinoma (IDC) with and without nodal metastasis, but no prognostic classification taking into consideration any biological differences between them is currently available. We previously investigated the histological characteristics that play an important role in tumour progression of IDCs according to their nodal status, and a new prognostic histological classification, the primary tumour–vessel tumour–nodal tumour (PVN) classification, was devised based on the histological characteristics of IDCs with and without nodal metastasis. Multivariate analyses using the Cox proportional hazard regression models were used to compare the ability of the PVN classification to predict tumour recurrence and death in 393 IDC patients based on the following histological classifications: (1) the pTNM classification, (2) the Nottingham Prognostic Index, (3) the modified Nottingham Prognostic Index, and (4) the histologic grade. In IDCs without nodal metastasis, only the PVN classification significantly increased the hazard rates (HRs) of tumour recurrence and death (P<0.05), independent of the hormone receptor status. Similarly, in IDCs with nodal metastases, only the PVN classification significantly increased the HRs of tumour recurrence and death (P<0.05), independent of the hormone receptor status. We conclude that the PVN prognostic histological classification is the best classification available for IDC of the breast. |
format | Text |
id | pubmed-2361891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23618912009-09-10 Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast Hasebe, T Sasaki, S Imoto, S Wada, N Ishii, G Ochiai, A Br J Cancer Clinical Study There are many studies that show biological differences between invasive ductal carcinoma (IDC) with and without nodal metastasis, but no prognostic classification taking into consideration any biological differences between them is currently available. We previously investigated the histological characteristics that play an important role in tumour progression of IDCs according to their nodal status, and a new prognostic histological classification, the primary tumour–vessel tumour–nodal tumour (PVN) classification, was devised based on the histological characteristics of IDCs with and without nodal metastasis. Multivariate analyses using the Cox proportional hazard regression models were used to compare the ability of the PVN classification to predict tumour recurrence and death in 393 IDC patients based on the following histological classifications: (1) the pTNM classification, (2) the Nottingham Prognostic Index, (3) the modified Nottingham Prognostic Index, and (4) the histologic grade. In IDCs without nodal metastasis, only the PVN classification significantly increased the hazard rates (HRs) of tumour recurrence and death (P<0.05), independent of the hormone receptor status. Similarly, in IDCs with nodal metastases, only the PVN classification significantly increased the HRs of tumour recurrence and death (P<0.05), independent of the hormone receptor status. We conclude that the PVN prognostic histological classification is the best classification available for IDC of the breast. Nature Publishing Group 2005-03-14 2005-03-01 /pmc/articles/PMC2361891/ /pubmed/15756255 http://dx.doi.org/10.1038/sj.bjc.6602353 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Study Hasebe, T Sasaki, S Imoto, S Wada, N Ishii, G Ochiai, A Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast |
title | Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast |
title_full | Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast |
title_fullStr | Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast |
title_full_unstemmed | Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast |
title_short | Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast |
title_sort | primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361891/ https://www.ncbi.nlm.nih.gov/pubmed/15756255 http://dx.doi.org/10.1038/sj.bjc.6602353 |
work_keys_str_mv | AT hasebet primarytumourvesseltumournodaltumourclassificationforpatientswithinvasiveductalcarcinomaofthebreast AT sasakis primarytumourvesseltumournodaltumourclassificationforpatientswithinvasiveductalcarcinomaofthebreast AT imotos primarytumourvesseltumournodaltumourclassificationforpatientswithinvasiveductalcarcinomaofthebreast AT wadan primarytumourvesseltumournodaltumourclassificationforpatientswithinvasiveductalcarcinomaofthebreast AT ishiig primarytumourvesseltumournodaltumourclassificationforpatientswithinvasiveductalcarcinomaofthebreast AT ochiaia primarytumourvesseltumournodaltumourclassificationforpatientswithinvasiveductalcarcinomaofthebreast |